Altravax is a biopharmaceutical company focused on the discovery and development of new vaccines and the improvement of existing vaccines to fight infectious diseases. Our vaccines are designed to elicit strong and appropriate immune responses that can prevent infections or treat existing ones. [Read more...]
Our product pipeline includes a tetravalent dengue vaccine, a vaccine for Hepatitis B and improved preventative vaccines for influenza and HIV-1.
Altravax is currently funded by the Department of Defense to apply our vaccine screening platform to several infectious disease targets.